These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8034878)

  • 41. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Underdiagnosis of VT due to cycle length variation among cardiac sarcoidosis patients having ICD: Problem with stability discriminator.
    Bera D; Pavri BB; Saggu DK; Devidutta S; Yalagudri S; Subramanian M; Sridevi C; Narasimhan C
    Pacing Clin Electrophysiol; 2020 Jun; 43(6):573-582. PubMed ID: 32320087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensing and detection in Medtronic implantable cardioverter defibrillators.
    Brown ML; Swerdlow CD
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):193-212. PubMed ID: 27624809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired detection of ventricular tachyarrhythmias by a rate-smoothing algorithm in dual-chamber implantable defibrillators: intradevice interactions.
    Glikson M; Beeman AL; Luria DM; Hayes DL; Friedman PA
    J Cardiovasc Electrophysiol; 2002 Apr; 13(4):312-8. PubMed ID: 12033344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tachycardia detection in modern implantable cardioverter-defibrillators.
    Brüggemann T; Dahlke D; Chebbo A; Neumann I
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):171-85. PubMed ID: 27576695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Considerations for ventricular fibrillation detection by implantable cardioverter defibrillators.
    Jones GK; Bardy GH
    Am Heart J; 1994 Apr; 127(4 Pt 2):1107-10. PubMed ID: 8160589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO).
    Toquero J; Alzueta J; Mont L; Lozano IF; Barrera A; Berruezo A; Castro V; Peña JL; Fidalgo ML; Brugada J
    Europace; 2009 Jun; 11(6):727-33. PubMed ID: 19411676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sinus rhythm R-wave amplitude as a predictor of ventricular fibrillation undersensing in patients with implantable cardioverter-defibrillator.
    Ruetz LL; Koehler JL; Brown ML; Jackson TE; Belk P; Swerdlow CD
    Heart Rhythm; 2015 Dec; 12(12):2411-8. PubMed ID: 26272520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sudden Cardiac Death Despite a Functional Cardioverter-Defibrillator: The Case for Early and Aggressive Therapy for Ventricular Tachycardia in Selected Patients.
    Montgomery JA; Kanagasundram AN; Clair WK; Rottman JN; Crossley GH
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):120-4. PubMed ID: 26511459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
    Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pacer-cardioverter-defibrillator: function and clinical experience.
    Friedman PA; Stanton MS
    J Cardiovasc Electrophysiol; 1995 Jan; 6(1):48-68. PubMed ID: 7743010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Underdetection of ventricular tachycardia by an implantable cardioverter-defibrillator due to a locally prolonged arrhythmia cycle length.
    Lee IO; Ukena C; Böhm M; Buob A; Neuberger HR
    Clin Res Cardiol; 2013 Dec; 102(12):923-5. PubMed ID: 23887832
    [No Abstract]   [Full Text] [Related]  

  • 58. [Optimized programming of sustained rate duration in patients with implantable cardioverter-defibrillators and diagnosed atrial fibrillation].
    Wieckhorst A; Buchwald AB; Unterberg C
    Z Kardiol; 1999 Jun; 88(6):426-33. PubMed ID: 10441813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.